Although p21 is predominantly considered a tumor suppressor, it can also exhibit oncogenic properties in certain conditions, e.g., by inhibiting drug-induced apoptosis in tumor cells, and/or promoting metastatic potential through cell motility [13]. Here, CDKN1A is linked to neoplasm.